2.69BMarket Cap-20074P/E (TTM)
19.165High18.395Low289.27KVolume18.910Open18.900Pre Close5.46MTurnover0.24%Turnover RatioLossP/E (Static)142.61MShares33.31052wk High1.85P/B2.32BFloat Cap14.56052wk Low--Dividend TTM123.16MShs Float93.940Historical High--Div YieldTTM4.07%Amplitude12.320Historical Low18.879Avg Price1Lot Size
Denali Therapeutics Stock Forum
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
ON THE WATCH: $33.07
FIRST SIGNED OF MORE UPTREND: $33.14
NEED IT TO BREAK OVER: $33.25
key indicator for MORE uptrend $33.50
confirmation uptrend - $33.68
mini breakout - $33.83. $Denali Therapeutics(DNLI.US)$
No comment yet